These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 32209836)

  • 21. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
    Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
    Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 24. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study.
    Riddle D; Gregoski M; Baker K; Dumas B; Jenkins CH
    Pharmacogenomics; 2016 Apr; 17(6):593-602. PubMed ID: 27023204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review.
    Meaddough EL; Sarasua SM; Fasolino TK; Farrell CL
    Pharmacogenomics J; 2021 Aug; 21(4):409-422. PubMed ID: 34140647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions.
    Hallberg P; Yue QY; Eliasson E; Melhus H; Ås J; Wadelius M
    Pharmacogenomics J; 2020 Aug; 20(4):579-585. PubMed ID: 31949290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The coming-of-age of pharmacogenetic testing in clinical psychiatry.
    Yoshida K; Müller DJ; Kennedy JL
    Psychiatry Clin Neurosci; 2019 May; 73(5):203. PubMed ID: 31045316
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
    Rakesh G; Sumner CR; Alexander JL; Gross LS; Pine J; Slaby A; Garakani A; Baron D
    J Nerv Ment Dis; 2020 Feb; 208(2):127-130. PubMed ID: 31895226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of pharmacogenetic testing in the treatment of bipolar disorder of Chinese patients.
    Huilei X; Siyu C; Jianghua X; Jidong R; Yi R
    Pharmacogenomics; 2020 Jul; 21(11):761-770. PubMed ID: 32597302
    [No Abstract]   [Full Text] [Related]  

  • 33. [How to manage polypharmacia?].
    Jäger S; Schricker S; Tremmel R; Schaeffeler E; Schwab M
    Dtsch Med Wochenschr; 2021 Jan; 146(1):23-29. PubMed ID: 33395723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of a pharmacogenomic program in a Brazilian public institution.
    Suarez-Kurtz G; Kovaleski G; Elias AB; Motta V; Wolch K; Emerenciano M; Mansur MB; Palladino AM; Accioly MT; Ferreira M; Gonçalves AA; de Melo AC
    Pharmacogenomics; 2020 Jun; 21(8):549-557. PubMed ID: 32378980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.
    Kimpton JE; Carey IM; Threapleton CJD; Robinson A; Harris T; Cook DG; DeWilde S; Baker EH
    Br J Clin Pharmacol; 2019 Dec; 85(12):2734-2746. PubMed ID: 31454087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics in Psychiatric Practice.
    El-Mallakh RS; Roberts RJ; El-Mallakh PL; Findlay LJ; Reynolds KK
    Clin Lab Med; 2016 Sep; 36(3):507-23. PubMed ID: 27514465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics and Psychiatric Nursing.
    White MM; Walker DK; Howington LL; Cheek DJ
    Issues Ment Health Nurs; 2019 Feb; 40(2):194-198. PubMed ID: 30451558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical validation of a psychiatric pharmacogenomic test.
    Jablonski MR; King N; Wang Y; Winner JG; Watterson LR; Gunselman S; Dechairo BM
    Per Med; 2018 May; 15(3):189-197. PubMed ID: 29739269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.